What Is Sermorelin?

Overview

Sermorelin is a synthetic 29-amino-acid peptide that reproduces the active N-terminal segment of human growth-hormone-releasing hormone (GHRH). Because the first 29 residues — known as GRF (1-29) — carry the full signalling capacity of the much larger native hormone, this shortened sequence behaves as a functional GHRH analog in research models. It is studied as a way to engage the body's own growth-hormone machinery rather than to introduce recombinant growth hormone directly.

How Sermorelin Works

The peptide binds the GHRH receptor on somatotroph cells of the anterior pituitary. Activation drives a cyclic-AMP second-messenger cascade that triggers the synthesis and pulsatile release of endogenous growth hormone. Because the stimulus passes through the pituitary's normal feedback loops, the resulting secretion follows physiological pulse patterns instead of the flat, supraphysiological levels associated with injected growth hormone. In combination research it is sometimes modelled alongside a growth-hormone-releasing peptide (GHRP) to study the complementary "GHRH + GHRP" signalling axis.

What the Research Explores

• Diagnostic testing of the growth-hormone axis and pituitary reserve.
• Growth-hormone deficiency models, including pediatric evaluation contexts.
• Pulsatile growth-hormone secretion dynamics and feedback regulation.
• Body-composition and lean-tissue endpoints (limited, exploratory evidence).
• Sleep-architecture and slow-wave-sleep associations (mechanistic plausibility only).

Forms & Handling

Sermorelin is typically supplied as a lyophilized powder, with research vials commonly available in 10 mg, 20 mg and 30 mg fills. It is reconstituted with bacteriostatic water for laboratory work — for example, adding 3.0 mL of bacteriostatic water to a 10 mg vial yields a concentration of roughly 3.33 mg/mL. Once in solution it is stored sealed and refrigerated at 2–8 °C, kept dark, and drawn with a fresh sterile syringe each time. See the dosing protocols below for the reconstitution math expressed in insulin-syringe units.

Safety & Research Notes

Sermorelin is treated here as an investigational research compound. While GHRH-analog chemistry has a history in clinical diagnostics, the material described on this page is intended strictly for laboratory study, with no approved human or veterinary use in this context and no established safety profile for administration. Reviews of growth-hormone augmentation in healthy older adults have reported limited benefit alongside increased adverse events, so claims around anti-aging or performance remain unsupported. Everything here is mechanistic background, not a usage recommendation.

References

Related Protocols